Skip to main content

SFA to host second annual ‘Words of Art’ collaborative exhibition


NACOGDOCHES, TEXAS – Formerly a course at Stephen F. Austin State University called “Pen & Pigment,” “Words of Art” is a student organization-led collaborative event that presents contributors with publication and exhibition opportunities.

Students who participated in “Pen & Pigment” engaged with one another to produce cohesive paintings and poetry that effectively correlated their disciplines.

Chemistry 3330 | All Instructors

Submitted by kouliavtsg@sfasu.edu on
  • Appointment: Book through TracCloud
  • Walk-In Table: No appointment needed
    • At the AARC
    • Monday: Noon to 2 p.m.
    • Tuesday: Noon to 5 p.m.
    • Wednesday: Noon to 4 p.m.
    • Thursday: 11 a.m. to 4 p.m.
    • Friday: 1 to 2 p.m.

SFA Repertory Dance Company to present ‘Omnium-gatherum’


NACOGDOCHES, Texas – New choreographic works created by the Stephen F. Austin State University dance faculty and guest artists Elias Kababa, Lacreacia Sanders and Torens Johnson will be featured in the program "Omnium-gatherum" presented Feb. 15 through 17 in W.M. Turner Auditorium, Griffith Fine Arts Building, on the SFA campus.

Comedian Zimmerman to perform in SFA’s University Series


NACOGDOCHES, Texas – The University Series at Stephen F. Austin State University brings comedian Joe Zimmerman to Nacogdoches for a performance at 7:30 p.m. Thursday, Feb. 22, in W.M. Turner Auditorium, Griffith Fine Arts Building, on the SFA campus.

A favorite of late-night shows such as “The Tonight Show,” “Last Comic Standing” and “Comedy Central,” Zimmerman is a frequent performer on university campuses and at corporate events.

SFA chemistry faculty member receives patent for a new type of antibiotic medication for resistant bacteria treatment


NACOGDOCHES, Texas — Dr. Matibur Zamadar, associate professor of chemistry and biochemistry at Stephen F. Austin State University, has received a patent from the U.S. Patent and Trademark Office for his second invention of a drug to treat bacteria that is resistant to most existing antibiotics and kills millions of people around the world with an invasive infection.

Subscribe to